Compare Indoco Remedies with Compact Disc - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES vs COMPACT DISC - Comparison Results

INDOCO REMEDIES     Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

COMPACT DISC 
   Change

Compact Disc Indai (CDI) is India's leading integrated media and entertainment company and South Asia's largest animation company with prime focus on animation outsourcing and production. Incorporated in 1992, its product range covers all the segment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDOCO REMEDIES COMPACT DISC INDOCO REMEDIES/
COMPACT DISC
 
P/E (TTM) x 122.8 -7.8 - View Chart
P/BV x 2.1 0.0 10,847.7% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 INDOCO REMEDIES   COMPACT DISC
EQUITY SHARE DATA
    INDOCO REMEDIES
Mar-18
COMPACT DISC
Mar-13
INDOCO REMEDIES/
COMPACT DISC
5-Yr Chart
Click to enlarge
High Rs31731 1,023.9%   
Low Rs1789 2,070.9%   
Sales per share (Unadj.) Rs113.10-  
Earnings per share (Unadj.) Rs4.5-0.3 -1,539.2%  
Cash flow per share (Unadj.) Rs11.8-0.2 -4,859.2%  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs73.289.7 81.6%  
Shares outstanding (eoy) m92.1512.75 722.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.2NM-  
Avg P/E ratio x55.5-68.2 -81.3%  
P/CF ratio (eoy) x21.0-81.4 -25.8%  
Price / Book Value ratio x3.40.2 1,533.1%  
Dividend payout %22.40-   
Avg Mkt Cap Rs m22,830252 9,043.4%   
No. of employees `0005.5NA-   
Total wages/salary Rs m2,2091 368,183.3%   
Avg. sales/employee Rs Th1,910.1NM-  
Avg. wages/employee Rs Th405.0NM-  
Avg. net profit/employee Rs Th75.5NM-  
INCOME DATA
Net Sales Rs m10,4190-  
Other income Rs m470-   
Total revenues Rs m10,4660-   
Gross profit Rs m1,349-3 -44,976.7%  
Depreciation Rs m6771 112,850.0%   
Interest Rs m2350-   
Profit before tax Rs m484-4 -13,444.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m720 72,400.0%   
Profit after tax Rs m412-4 -11,124.3%  
Gross profit margin %12.9NM- 
Effective tax rate %15.0-2.8 -538.5%   
Net profit margin %4.0NM- 
BALANCE SHEET DATA
Current assets Rs m5,373627 857.5%   
Current liabilities Rs m4,157157 2,649.4%   
Net working cap to sales %11.7NM- 
Current ratio x1.34.0 32.4%  
Inventory Days Days68NM- 
Debtors Days Days73NM- 
Net fixed assets Rs m6,24425 24,877.1%   
Share capital Rs m184127 144.9%   
"Free" reserves Rs m6,5661,017 645.5%   
Net worth Rs m6,7501,144 589.9%   
Long term debt Rs m1,233178 694.5%   
Total assets Rs m12,3631,480 835.5%  
Interest coverage x3.1NM-  
Debt to equity ratio x0.20.2 117.7%  
Sales to assets ratio x0.80-   
Return on assets %5.2-0.3 -2,091.9%  
Return on equity %6.1-0.3 -1,885.9%  
Return on capital %9.0-0.3 -3,307.6%  
Exports to sales %0NM-  
Imports to sales %0NM-  
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3,7620-   
Fx outflow Rs m1,1430-   
Net fx Rs m2,6190-   
CASH FLOW
From Operations Rs m1,2270 409,066.7%  
From Investments Rs m-1,360-1 226,683.3%  
From Financial Activity Rs m-388NA-  
Net Cashflow Rs m-5210 173,533.3%  

Share Holding

Indian Promoters % 59.2 22.6 261.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 12.5 0.0 -  
FIIs % 6.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 22.4 77.4 28.9%  
Shareholders   12,805 28,898 44.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDOCO REMEDIES With:   TVS SRICHAKRA  TATA INVESTMENT  REPCO HOME  GREENPLY INDUSTRIES  FINOLEX INDUSTRIES  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (1QFY20); Net Profit Up 118.1% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, INDOCO REMEDIES has posted a net profit of Rs 22 m (up 118.1% YoY). Sales on the other hand came in at Rs 3 bn (up 16.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Jun 6, 2019 | Updated on Jun 6, 2019

For the quarter ended March 2019, INDOCO REMEDIES has posted a net profit of Rs 116 m (down 43.3% YoY). Sales on the other hand came in at Rs 3 bn (down 6.5% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

INDOCO REMEDIES Announces Quarterly Results (3QFY19); Net Profit Down 76.4% (Quarterly Result Update)

Jan 24, 2019 | Updated on Jan 24, 2019

For the quarter ended December 2018, INDOCO REMEDIES has posted a net profit of Rs 53 m (down 76.4% YoY). Sales on the other hand came in at Rs 3 bn (down 5.6% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (2QFY19); Net Profit Down 139.4% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, INDOCO REMEDIES has posted a net profit of Rs 78 m (down 139.4% YoY). Sales on the other hand came in at Rs 2 bn (down 17.3% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Oct 18, 2019 (Close)

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES - TVS SRICHAKRA COMPARISON

COMPARE INDOCO REMEDIES WITH

MARKET STATS